Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight.
Pagibaximab functions as a chimeric monoclonal antibody aimed at preventing staphylococcal sepsis in newborns with low birth weight.